# Sirakoss

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sirakoss

- Industry: Medical Devices & Equipment
- Headquarters: Aberdeen, UK
- Website: www.sirakoss.com
- Total disclosed funding: $3.5M
- Latest round: Series A (Nov 24, 2014)
- Investors on record: 3

## About

Sirakoss Ltd. specializes in developing advanced orthobiologics solutions aimed at enhancing natural healing through innovative products.Founded in 2010 and headquartered in Aberdeen, UK, Sirakoss Ltd. develops orthobiologics products that facilitate healing. The company was acquired by OssDsign AB in November 2020 for USD 11 mn. The founder's specific background is not publicly available, and there are no mentions of prior companies established by them. Sirakoss has completed 3 notable deals, with its latest funding round being an Add-on Trade Sale which occurred on 2020-11-03, raising a total of USD 2.21 mn.Sirakoss Ltd. focuses on producing advanced orthobiologics products, particularly the OssDsign Catalyst, a nanosynthetic bone graft putty designed to enhance bone integration during surgical procedures. Their client base includes hospitals and orthopedic surgeons across North America and Europe, who utilize these products for better patient recovery outcomes in complex surgeries.In the most recent fiscal year of 2023, Sirakoss Ltd. reported a revenue of USD 460,007.2 and an EBITDA of USD 73,940.7, showcasing its financial activity primarily driven by sales of its proprietary products to healthcare institutions.Sirakoss Ltd. plans to leverage its recent funding received from the acquisition by OssDsign AB to further develop its product line and expand into new markets. With a focus on innovative solutions, the company is exploring upcoming product launches aimed at enhancing surgical outcomes. The acquisition deal on 2020-11-03 has positioned Sirakoss for strategic growth, allowing it to tap into OssDsign's resources and expertise as it seeks to broaden its reach in the orthobiologics market.

## Funding rounds

- Series A, Nov 24, 2014, $3.5M — Epidarex Capital, Scottish Enterprise, The Armourers & Brasiers Company

## Investors

- Epidarex Capital (https://capitalatlas.ai/funds/epidarex-capital) — Series A
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Series A
- The Armourers & Brasiers Company — Series A